Search results
Results from the WOW.Com Content Network
IMS stood for Intercontinental Medical Statistics. It was the largest vendor of U.S. physician prescribing data. [2] [3] [4] IMS Health was founded in 1954 by Bill Frohlich and David Dubow with Arthur Sackler having a hidden ownership stake. [5] In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green ...
[28] [29] IMS Health shareholders received 0.384 shares of Quintiles common stock for each share of IMS Health common stock they held, leaving the split of ownership at 51.4% IMS and 48.6% Quintiles. [ 30 ] [ 31 ] The merger was completed in October and the resulting company was a $17.6 billion company called QuintilesIMS. [ 9 ]
In 1994, he took Quintiles public through an IPO. [6] Quintiles is the "largest global provider of clinical trials and commercial marketing services to the pharmaceutical and biotechnology industry". [5] In December 2015, Gillings retired as executive chairman of Quintiles, but remains a director. [6]
The 5-quantiles are called quintiles or pentiles → QU; The 6-quantiles are called sextiles → S; The 7-quantiles are called septiles → SP; The 8-quantiles are called octiles → O; The 10-quantiles are called deciles → D; The 12-quantiles are called duo-deciles or dodeciles → DD; The 16-quantiles are called hexadeciles → H
Data compiled by American company Quintiles IMS showed China's share of global demand for immunosuppressant drugs, which are necessary to prevent the bodies of patients from rejecting transplanted organs, were approximately in line with the proportion of global transplants China said it performed. [8]
Its new name maintains parts of its original formation, with the ‘I’ representing IMS and the ‘Q’ taken from Quintiles. However, the latter and newest part of the name - ‘via’ - is representative of “seeking to inspire and ignite real change via a new path forward”, explains Ari Bousbib, chief executive officer of IQVIA."
IMS TM provides a standard environment for transaction execution. Several Chinese banks had purchased IMS by the late 2000s to support the country's burgeoning financial industry. [11] IMS complements IBM Db2, IBM's relational database system introduced in 1982. IMS generally performs faster than Db2 for common tasks, but may require more ...
However, in the mid-1990s the industry, through third-party prescribing data (e.g., Quintiles/IMS) switched to "script-tracking" [10] technologies, measuring the number of total prescriptions (TRx) and new prescriptions (NRx) per week that each physician writes. This information is collected by commercial vendors.